Is there a future for selective estrogen-receptor modulators in osteoporosis?

被引:6
作者
Gueerri-Fernandez, Roberto C. [2 ,3 ]
Diez-Perez, Adolfo [1 ]
机构
[1] Hosp Mar, Dept Internal Med, P Maritim 25-29, Barcelona 08003, Spain
[2] Autonomous Univ Barcelona, Hosp Mar IMIM, Dept Internal Med, Barcelona, Spain
[3] Inst Carlos III, RETICEF, Barcelona, Spain
关键词
D O I
10.1177/1759720X11435677
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
引用
收藏
页码:55 / 59
页数:5
相关论文
共 29 条
[1]
Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0
[2]
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women [J].
Barrett-Connor, Elizabeth ;
Mosca, Lori ;
Collins, Peter ;
Geiger, Mary Jane ;
Grady, Deborah ;
Kornitzer, Marcel ;
McNabb, Michelle A. ;
Wenger, Nanette K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (02) :125-137
[3]
The Aftermath of Hip Fracture: Discharge Placement, Functional Status Change, and Mortality [J].
Bentler, Suzanne E. ;
Liu, Li ;
Obrizan, Maksym ;
Cook, Elizabeth A. ;
Wright, Kara B. ;
Geweke, John F. ;
Chrischilles, Elizabeth A. ;
Pavlik, Claire E. ;
Wallace, Robert B. ;
Ohsfeldt, Robert L. ;
Jones, Michael P. ;
Rosenthal, Gary E. ;
Wolinsky, Fredric D. .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 170 (10) :1290-1299
[4]
Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures [J].
Black, DM ;
Arden, NK ;
Palermo, L ;
Pearson, J ;
Cummings, SR .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (05) :821-828
[5]
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].
Black, DM ;
Cummings, SR ;
Karpf, DB ;
Cauley, JA ;
Thompson, DE ;
Nevitt, MC ;
Bauer, DC ;
Genant, HK ;
Haskell, WL ;
Marcus, R ;
Ott, SM ;
Torner, JC ;
Quandt, SA ;
Reiss, TF ;
Ensrud, KE .
LANCET, 1996, 348 (9041) :1535-1541
[6]
Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies [J].
Byrjalsen, I. ;
Leeming, D. J. ;
Qvist, P. ;
Christiansen, C. ;
Karsdal, M. A. .
OSTEOPOROSIS INTERNATIONAL, 2008, 19 (03) :339-348
[7]
Selective estrogen receptor modulators: Clinical spectrum [J].
Cosman, F ;
Lindsay, R .
ENDOCRINE REVIEWS, 1999, 20 (03) :418-434
[8]
The effect of raloxifene on risk of breast cancer in postmenopausal women - Results from the MORE randomized trial [J].
Cummings, SR ;
Eckert, S ;
Krueger, KA ;
Grady, D ;
Powles, TJ ;
Cauley, JA ;
Norton, L ;
Nickelsen, T ;
Bjarnason, NH ;
Morrow, M ;
Lippman, ME ;
Black, D ;
Glusman, JE ;
Costa, A ;
Jordan, VC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (23) :2189-2197
[9]
Arzoxifene for Prevention of Fractures and Invasive Breast Cancer in Postmenopausal Women [J].
Cummings, Steven R. ;
McClung, Michael ;
Reginster, Jean-Yves ;
Cox, David ;
Mitlak, Bruce ;
Stock, John ;
Amewou-Atisso, Messan ;
Powles, Trevor ;
Miller, Paul ;
Zanchetta, Jose ;
Christiansen, Claus .
JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (02) :397-404
[10]
Lasofoxifene in Postmenopausal Women with Osteoporosis [J].
Cummings, Steven R. ;
Ensrud, Kristine ;
Delmas, Pierre D. ;
LaCroix, Andrea Z. ;
Vukicevic, Slobodan ;
Reid, David M. ;
Goldstein, Steven ;
Sriram, Usha ;
Lee, Andy ;
Thompson, John ;
Armstrong, Roisin A. ;
Thompson, David D. ;
Powles, Trevor ;
Zanchetta, Jose ;
Kendler, David ;
Neven, Patrick ;
Eastell, Richard .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (08) :686-696